Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 307

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial

Open access
Banovic, Marko, Putnik, Svetozar, Penicka, Martin, Doros, Gheorghe, Deja, Marek A., Kockova, Radka, Kotrc, Martin, Glaveckaite, Sigita, Gasparovic, Hrvoje, Pavlovic, Nikola, Velicki, Lazar, Salizzoni, Stefano, Wojakowski, Wojtek, Van Camp, Guy, Nikolic, Serge D., Iung, Bernard, Bartunek, Jozef, Barbato, Emanuele, De Bruyne, Bernard, Casselman, Filip, De Grieck, Ivan, Heyse, Alex, Stockman, Bernard, Vanderheyden, Marc, Van Durme, Frederik, Van Praet, Frank, Wyffels, Eric, Biocina, Bojan, Manola, Sime, Pirk, Jan, Cura-Stura, Erik, Rinaldi, Mauro, Maria De Ferrari, Gaetano, Fava, Antonella, Maria Richiardi, Elena, Celutkiene, Jelena, Filipova, Marta, Ciosek, Joanna, Guzy, Michal, Kurzelowski, Radoslaw, Wojakowski, Wojtek, Bjelobrk, Marija, Ilic, Aleksandra, Kovacevic, Mila, Miljkovic, Tatjana, Preveden, Andrej, Srdanovic, Ilija, Aleksandric, Srdjan, Asanin, Milika, Beleslin, Branko, Bojanic, Milica, Boskovic, Nikola, Bosic, Sladjana, Cvetinovic, Natasa, Dedovic, Vladimir, Giga, Vojislav, Jandric, Predrag, Jaukovic, Milena, Jovanovic, Miodrag, Kovacevic-Kuzmanovic, Ana, Loncar, Goran, Manojlovic, Andrea, Matkovic, Milos, Mitrovic, Predrag, Nedeljkovic, Ivana, Nedeljkovic, Milan, Petrovic, Olgica, Ristic, Arsen, Seper, Mirjana, Simic, Dragan, Stankovic, Sanja, Stojkovic, Sinisa, Vukcevic, Vladan, Zivic, Katarina · 2022 · Circulation

Abstract

Background: Surgical aortic valve replacement (SAVR) represents a class I indication in symptomatic patients with severe aortic stenosis (AS). However, indications for early SAVR in asymptomatic patients with severe AS and normal left ventricular function remain debated. Methods: The AVATAR trial (Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis) is an investigator-initiated international prospective randomized controlled trial that evaluated the safety and efficacy of early SAVR in the treatment of asymptomatic patients with severe AS, according to common criteria (valve area ≤1 cm 2 with aortic jet velocity >4 m/s or a mean transaortic gradient ≥40 mm Hg), and with normal left ventricular function. Negative exercise testing was mandatory for inclusion. The primary hypothesis was that early SAVR would reduce the primary composite end point of all-cause death, acute myocardial infarction, stroke, or unplanned hospitalization for heart failure compared with a conservative strategy according to guidelines. The trial was designed as event-driven to reach a minimum of 35 prespecified events. The study was performed in 9 centers in 7 European countries. Results: Between June 2015 and September 2020, 157 patients (mean age, 67 years; 57% men) were randomly allocated to early surgery (n=78) or conservative treatment (n=79). Follow-up was completed in May 2021. Overall median follow-up was 32 months: 28 months in the early surgery group and 35 months in the conservative treatment group. There was a total of 39 events, 13 in early surgery and 26 in the conservative treatment group. In the early surgery group, 72 patients (92.3%) underwent SAVR with operative mortality of 1.4%. In an intention-to-treat analysis, patients randomized to early surgery had a significantly lower incidence of primary composite end point than those in the conservative arm (hazard ratio, 0.46 [95% CI, 0.23–0.90]; P =0.02). There was no statistical difference in secondary end points, including all-cause mortality, first heart failure hospitalizations, major bleeding, or thromboembolic complications, but trends were consistent with the primary outcome. Conclusions: In asymptomatic patients with severe AS, early surgery reduced a primary composite of all-cause death, acute myocardial infarction, stroke, or unplanned hospitalization for heart failure compared with conservative treatment. This randomized trial provides preliminary support for early SAVR once AS becomes severe, regardless of symptoms. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02436655.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.121.057639

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 307

Metadata

Authors
Banovic, M., Putnik, S., Penicka, M., Doros, G., Deja, M. A., Kockova, R., Kotrc, M., Glaveckaite, S., Gasparovic, H., Pavlovic, N., Velicki, L., Salizzoni, S., Wojakowski, W., Van Camp, G., Nikolic, S. D., Iung, B., Bartunek, J., Barbato, E., De Bruyne, B., Casselman, F., De Grieck, I., Heyse, A., Stockman, B., Vanderheyden, M., Van Durme, F., Van Praet, F., Wyffels, E., Biocina, B., Manola, S., Pirk, J., Cura-Stura, E., Rinaldi, M., Maria De Ferrari, G., Fava, A., Maria Richiardi, E., Celutkiene, J., Filipova, M., Ciosek, J., Guzy, M., Kurzelowski, R., Wojakowski, W., Bjelobrk, M., Ilic, A., Kovacevic, M., Miljkovic, T., Preveden, A., Srdanovic, I., Aleksandric, S., Asanin, M., Beleslin, B., Bojanic, M., Boskovic, N., Bosic, S., Cvetinovic, N., Dedovic, V., Giga, V., Jandric, P., Jaukovic, M., Jovanovic, M., Kovacevic-Kuzmanovic, A., Loncar, G., Manojlovic, A., Matkovic, M., Mitrovic, P., Nedeljkovic, I., Nedeljkovic, M., Petrovic, O., Ristic, A., Seper, M., Simic, D., Stankovic, S., Stojkovic, S., Vukcevic, V., & Zivic, K.
Venue
Circulation
Published
2022-03
Volume
145
Issue
9
Pages
648-658
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W3212990746
Cited by
307
References
24
FWCI
27.50
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.